市場調査レポート
商品コード
1386130
腸チフスワクチン市場レポート:2030年までの動向、予測、競合分析Typhoid Fever Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
腸チフスワクチン市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
世界の腸チフスワクチン市場は、2024年から2030年までのCAGRが14.5%で、2030年までに推定10億米ドルに達すると予測されます。この市場の主な促進要因は、腸チフスの有病率の上昇と、複数の疾患に対する予防効果を持つ混合ワクチンの需要の高まりです。腸チフスワクチンの世界市場の将来は、病院・診療所市場や専門センター市場にビジネスチャンスがあり、有望視されています。
Lucintelの予測によると、莢膜多糖体は、細菌からの感染を防ぐ効率が高く、副作用が少なく安全で、経口または注射による投与が可能であるため、使用が簡単で便利であることから、予測期間中に最も高い成長が見込まれます。
この市場の中では、病院・診療所が予測期間中に最も高い成長を遂げると予想されます。
北米は、あらゆる年齢層でワクチン需要が増加しており、腸チフスワクチンに対する認知度も高いことから、引き続き最大の市場です。
市場規模・推計:腸チフスワクチンの市場規模を金額(10億米ドル)で推計。
動向と予測分析:各種セグメント別、地域別の市場動向(2018年~2023年)と予測(2024年~2030年)。
セグメント別分析:腸チフスワクチン市場規模をタイプ別、投与経路別、最終用途別、地域別に金額(10億米ドル)で推計。
地域別分析:腸チフスワクチン市場の北米、欧州、アジア太平洋地域、その他世界のその他の地域内訳。
成長機会:腸チフスワクチン市場のタイプ別、投与経路別、最終用途別、地域別の成長機会分析。
戦略分析:腸チフスワクチン市場のM&A、新製品開発、競合情勢など。
ポーターのファイブフォースモデルに基づく業界の競合強度分析。
The future of the global typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets. The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 14.5% from 2024 to 2030. The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global typhoid fever vaccine by type, route of administration, end use, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies typhoid fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the typhoid fever vaccine companies profiled in this report include-
Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.
Within this market, hospital & clinic is expected to witness highest growth over the forecast period.
North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.
Market Size Estimates: Typhoid fever vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Typhoid fever vaccine market size by type, route of administration, end use, and region in terms of value ($B).
Regional Analysis: Typhoid fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, route of administration, end uses, and regions for the typhoid fever vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the typhoid fever vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Answer: The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030.
Answer: The global typhoid fever vaccine market is expected to grow with a CAGR of 14.5% from 2024 to 2030.
Answer: The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.
Answer: The future of the typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets.
Answer: Some of the key typhoid fever vaccine companies are as follows:
Answer: Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.
Answer: North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.
Answer: Yes, Lucintel provides 10% customization without any additional cost.